Cargando…

Biphasic Mathematical Model of Cell–Drug Interaction That Separates Target-Specific and Off-Target Inhibition and Suggests Potent Targeted Drug Combinations for Multi-Driver Colorectal Cancer Cells

Quantifying the response of cancer cells to a drug, and understanding the mechanistic basis of the response, are the cornerstones for anti-cancer drug discovery. Classical single target-based IC(50) measurements are inadequate at describing cancer cell responses to targeted drugs. In this study, bas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Jinyan, Li, Li, Yang, Tao, Cohen, Paul S., Sun, Gongqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072552/ https://www.ncbi.nlm.nih.gov/pubmed/32069833 http://dx.doi.org/10.3390/cancers12020436

Ejemplares similares

Application of a Biphasic Mathematical Model of Cancer Cell Drug Response for Formulating Potent and Synergistic Targeted Drug Combinations to Triple Negative Breast Cancer Cells
por: Shen, Jinyan, et al.
Publicado: (2020)

Drug Sensitivity Screening and Targeted Pathway Analysis Reveal a Multi-Driver Proliferative Mechanism and Suggest a Strategy of Combination Targeted Therapy for Colorectal Cancer Cells
por: Shen, Jinyan, et al.
Publicado: (2019)

Small molecules targeting Pin1 as potent anticancer drugs
por: Zhang, Jing, et al.
Publicado: (2023)

AMPK and Polycystic Kidney Disease Drug Development: An Interesting Off-Target Target
por: Caplan, Michael J.
Publicado: (2022)

Small molecules as potent biphasic modulators of protein liquid-liquid phase separation
por: Babinchak, W. Michael, et al.
Publicado: (2020)

Targeted drug combination therapy design based on driver genes
por: Zsákai, Lilian, et al.
Publicado: (2019)

Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates
por: Jain, Surbhi, et al.
Publicado: (2022)

Subtractive proteomics analysis to uncover the potent drug targets for distinctive drug design of Candidaauris
por: Bappy, Md. Nazmul Islam, et al.
Publicado: (2023)

Empowering drug off-target discovery with metabolic and structural analysis
por: Chowdhury, Sourav, et al.
Publicado: (2023)

Challenges and Opportunities in Developing Targeted Therapies for Triple Negative Breast Cancer
por: Chapdelaine, Abygail G., et al.
Publicado: (2023)

On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2
por: Sauvat, Allan, et al.
Publicado: (2020)

Carbon Nanotubes—Potent Carriers for Targeted Drug Delivery in Rheumatoid Arthritis
por: Kofoed Andersen, Camilla, et al.
Publicado: (2021)

Controllability in Cancer Metabolic Networks According to Drug Targets as Driver Nodes
por: Asgari, Yazdan, et al.
Publicado: (2013)

Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multistage Antimalarial Drug
por: da Cruz, Filipa P., et al.
Publicado: (2012)

Identification of Lethal Inhibitors and Inhibitor Combinations for Mono-Driver versus Multi-Driver Triple-Negative Breast Cancer Cells
por: Ku, Geng Chia, et al.
Publicado: (2022)

CD166-specific CAR-T cells potently target colorectal cancer cells
por: He, Shuai, et al.
Publicado: (2022)

Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces
por: Zheng, Yi, et al.
Publicado: (2019)

Off-Target Effects of Drugs that Disrupt Human Mitochondrial DNA Maintenance
por: Young, Matthew J.
Publicado: (2017)

A framework for identification of on- and off-target transcriptional responses to drug treatment
por: Huang, Yi, et al.
Publicado: (2019)

Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects
por: Chartier, Matthieu, et al.
Publicado: (2017)

Are Pharmaceuticals with Evolutionary Conserved Molecular Drug Targets More Potent to Cause Toxic Effects in Non-Target Organisms?
por: Furuhagen, Sara, et al.
Publicado: (2014)

Massively targeted evaluation of therapeutic CRISPR off-targets in cells
por: Pan, Xiaoguang, et al.
Publicado: (2022)

Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity
por: Pogue, Sarah L., et al.
Publicado: (2016)

Cell-mediated targeting drugs delivery systems
por: Yu, Hongli, et al.
Publicado: (2020)

Controversies in Targeted Therapy of Adult T Cell Leukemia/Lymphoma: ON Target or OFF Target Effects?
por: Nasr, Rihab, et al.
Publicado: (2011)

Evolutionary triage governs fitness in driver and passenger mutations and suggests targeting never mutations
por: Gatenby, R A., et al.
Publicado: (2014)

The Effects of Quinone Imine, a New Potent Nitrification Inhibitor, Dicyandiamide, and Nitrapyrin on Target and Off-Target Soil Microbiota
por: Papadopoulou, Evangelia S., et al.
Publicado: (2022)

Drugs and Targets in Fibrosis
por: Li, Xiaoyi, et al.
Publicado: (2017)

Gene expression in primary and metastatic kidney cancer to discover drivers of metastasis and targets for drug development
por: Zhao, Amy, et al.
Publicado: (2015)

Targeted cell elimination reveals an auxin-guided biphasic mode of lateral root initiation
por: Marhavý, Peter, et al.
Publicado: (2016)

Off-Target Effects of Psychoactive Drugs Revealed by Genome-Wide Assays in Yeast
por: Ericson, Elke, et al.
Publicado: (2008)

Identification of Distant Drug Off-Targets by Direct Superposition of Binding Pocket Surfaces
por: Schumann, Marcel, et al.
Publicado: (2013)

Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia
por: Kuenzi, Brent M., et al.
Publicado: (2019)

Drug-drug relationship based on target information: application to drug target identification
por: Park, Keunwan, et al.
Publicado: (2011)

Introduction to Drugs and Drug Targets
por: Zanders, Edward D.
Publicado: (2011)

Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target
por: Franses, Joseph W., et al.
Publicado: (2020)

Elimination of Cas9-dependent off-targeting of adenine base editor by using TALE to separately guide deaminase to target sites
por: Liu, Yang, et al.
Publicado: (2022)

The nuclear export inhibitor aminoratjadone is a potent effector in extracellular-targeted drug conjugates
por: Klahn, Philipp, et al.
Publicado: (2019)

Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues
por: Seal, Jennifer R., et al.
Publicado: (2019)

A novel algorithm for finding optimal driver nodes to target control complex networks and its applications for drug targets identification
por: Guo, Wei-Feng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qfgb0nfmle80dra0hcppjsflnt